PMID: 33821640 Eur J Med ChemDiscovery of (E)-N-(4-methyl-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thiazol-2-yl)-2-(4-methylpiperazin-1-yl)acetamide (IHMT-TRK-284) as a novel orally available type II TRK kinase inhibitor capable of overcoming multiple resistant mutants
Such events could generate unpredictable phenotypes and disrupt intestinal ecosystem dynamics
Key Features Directions for Use Adults: Take 1 capsule one to two times a day, or as professionally prescribed
Learn more about Phosphatidylcholine We don't have a description for Manganese Sulfate yet
J Proteome Res 10:6684 Borude P, Edwards G, Walesky C, Li F, Ma X, Kong B, Guo GL, Apte U (2012) Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice
To help set the stage, the chart below outlines how different ALA dosages have been used in clinical research and what kinds of results theyre associated with